Apricity, a UK-based virtual fertility clinic, has raised €17 million in a Series B round led by MTIP, the Swiss healthtech investor, with participation from Barcelona-based specialist consumer fund Iris Ventures.
The new funds will be used to accelerate Apricity’s growth in the UK, expand geographically (to Spain before the end of the year, followed by Germany and Italy), and further develop its technology, as it continues on its mission to become the leading fertility player in Europe. This includes expanding its at-home services to include at-home ultrasound scans in select areas.
Launched in the UK in 2018 and originally incubated by Kamet Ventures, Apricity combines fertility care with technology to increase the chances of conception and outperform traditional clinics, while offering a smoother patient experience. The service assists with every step of the fertility treatment journey, and provides continuous, personalised support through its app. With one-in-six couples having difficulty conceiving, Apricity boasts a 46% success rate per cycle, compared to a UK average of 31%. Meanwhile, the global fertility market is predicted to hit $26 billion by 2027.
